Clinical Trials
4
Active:1
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:3
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
3 (75.0%)Phase 1
1 (25.0%)A Study of Lidocaine Pertubation as a Treatment for Unexplained Infertility
Phase 2
- Conditions
- Unexplained Infertility
- Interventions
- Drug: BufferDrug: Isifera+
- First Posted Date
- 2017-12-29
- Last Posted Date
- 2017-12-29
- Lead Sponsor
- Isifer AB
- Target Recruit Count
- 120
- Registration Number
- NCT03386552
- Locations
- 🇵🇱
InviMed-T sp. z o.o, Warszawa, Poland
Pertubation With Lignocaine in Endometriosis
Phase 2
Completed
- Conditions
- EndometriosisDysmenorrhea
- Interventions
- First Posted Date
- 2011-04-06
- Last Posted Date
- 2011-04-06
- Lead Sponsor
- Isifer AB
- Target Recruit Count
- 42
- Registration Number
- NCT01329796
- Locations
- 🇸🇪
Läkargruppen Victoria Söderhallarna 120, Stockholm, Sweden
🇸🇪Karolinska Institute, Fertility Unit, K59 Karolinska University Hospital at Huddinge, Stockholm, Sweden
🇸🇪Department of Gynaecology and Obstetrics Danderyd Hospital, Stockholm, Sweden
A Phase II Clinical Study of Lidocain Pertubation as Treatment for Couples With Unexplained Infertility
Phase 2
Completed
- Conditions
- Infertility
- First Posted Date
- 2007-03-20
- Last Posted Date
- 2007-03-20
- Lead Sponsor
- Isifer AB
- Target Recruit Count
- 330
- Registration Number
- NCT00449449
- Locations
- 🇸🇪
1. Department of Obstetrics and Gynecology, Karolinska University Hospital at Huddinge, Stockholm, Sweden
News
No news found